• Study on Midostaurin and Chemotherapy for Children with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Czechia Germany Italy Poland Slovenia

  • Study on the Long-Term Safety and Effects of OMS906 for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on the Safety and Activity of S095029 and Pembrolizumab for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Denmark France Hungary Italy +1

  • Study on Reversing HIV Latency Using Pyrimethamine, Lenalidomide, and Panobinostat for People Living with HIV

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Hungary Italy Poland Spain Sweden

  • Study on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Czechia France Germany +6

  • Study of Different Doses of Amlitelimab Given by Injection Under the Skin in Adults with Moderate to Severe Asthma

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Hungary Italy Poland

  • Study on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Hungary +2

  • Study on Sentinel Node Detection in Early-Stage Cervical Cancer Using Indocyanine Green Compared to 99mTc and Blue Dye

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Selumetinib for Children Aged 1 to 6 with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Spain

powered by